Back to top

Quest Diagnostics to offer FDA-cleared Roche pTau217 blood test

Quest Diagnostics (DGX) announced two new developments for its Quest AD-Detect portfolio of blood-based biomarker tests for Alzheimer’s disease, wi...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Quest Diagnostics Incorporated (DGX)

Roche Holding AG (RHHBY)

Rogers Corporation (ROG)

Roper Technologies, Inc. (ROP)